AMENDMENT NUMBER 3 TO MANUFACTURE, LICENSE AND DISTRIBUTION AGREEMENTManufacture, License and Distribution Agreement • March 24th, 2010 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances
This Amendment Number 3 to the Manufacture, License and Distribution Agreement by and between Perrigo Company of South Carolina, Inc. (“Perrigo”), and SCOLR Pharma, Inc. (“SCOLR”) dated October 20, 2005, as amended by Amendment Number 1 dated November 14, 2008 and Amendment Number 2 dated April 24, 2009 (the “Agreement”) is dated as of January 4, 2010 and effective as of January 1, 2010 (the “Amendment Effective Date”).
MANUFACTURE, LICENSE AND DISTRIBUTION AGREEMENT BY AND BETWEEN PERRIGO COMPANY OF SOUTH CAROLINA, INC. AND SCOLR PHARMA, INC. October 20, 2005Manufacture, License and Distribution Agreement • March 23rd, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS LICENSE AGREEMENT (this “Agreement”), is entered into as of October 20, 2005, by and between Perrigo Company of South Carolina, Inc., a Michigan corporation, with offices at 515 Eastern Avenue, Allegan, Michigan 49010 (“Perrigo”), and SCOLR Pharma, Inc., a Delaware corporation, with offices at 3625 132nd Avenue SE, Suite 300, Bellevue, Washington 98006 (together with its Affiliates, collectively, “SCOLR Pharma”).
